Literature DB >> 21607858

Determining allosteric modulator mechanism of action: integration of radioligand binding and functional assay data.

Christopher J Langmead1.   

Abstract

The drive to produce safer and more receptor subtype selective drugs has sparked a renewed interest in allosteric modulators of G protein-coupled receptors. The increasing use of functional assays has shown that allosteric ligands are capable of modulating both orthosteric agonist affinity and efficacy, as well as mediating receptor activation in their own right. Such a complex range of behaviours can be difficult to discern from single datasets; this chapter seeks to explain how to use radioligand binding and functional assay datasets in concert to elucidate allosteric modulator mechanism of action.

Mesh:

Substances:

Year:  2011        PMID: 21607858     DOI: 10.1007/978-1-61779-126-0_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Drug Design Strategies for GPCR Allosteric Modulators.

Authors:  P Jeffrey Conn; Scott D Kuduk; Darío Doller
Journal:  Annu Rep Med Chem       Date:  2012       Impact factor: 1.059

2.  Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.

Authors:  Seungkirl Ahn; Alem W Kahsai; Biswaranjan Pani; Qin-Ting Wang; Shuai Zhao; Alissa L Wall; Ryan T Strachan; Dean P Staus; Laura M Wingler; Lillian D Sun; Justine Sinnaeve; Minjung Choi; Ted Cho; Thomas T Xu; Gwenn M Hansen; Michael B Burnett; Jane E Lamerdin; Daniel L Bassoni; Bryant J Gavino; Gitte Husemoen; Eva K Olsen; Thomas Franch; Stefano Costanzi; Xin Chen; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-27       Impact factor: 11.205

Review 3.  Approaches for probing allosteric interactions at 7 transmembrane spanning receptors.

Authors:  Michael T Klein; Paige N Vinson; Colleen M Niswender
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

4.  Co-operative binding assay for the characterization of mGlu4 allosteric modulators.

Authors:  Pekka Poutiainen; Kun-Eek Kil; Zhaoda Zhang; Darshini Kuruppu; Bakhos Tannous; Anna-Liisa Brownell
Journal:  Neuropharmacology       Date:  2015-05-27       Impact factor: 5.250

5.  Mechanism of β2AR regulation by an intracellular positive allosteric modulator.

Authors:  Xiangyu Liu; Ali Masoudi; Alem W Kahsai; Li-Yin Huang; Biswaranjan Pani; Dean P Staus; Paul J Shim; Kunio Hirata; Rishabh K Simhal; Allison M Schwalb; Paula K Rambarat; Seungkirl Ahn; Robert J Lefkowitz; Brian Kobilka
Journal:  Science       Date:  2019-06-27       Impact factor: 47.728

Review 6.  Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target.

Authors:  David R Janero; Ganesh A Thakur
Journal:  Expert Opin Drug Discov       Date:  2016-10-21       Impact factor: 6.098

7.  A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique Gi-functional Bias.

Authors:  Daniele Bolognini; Catherine E Moss; Karolina Nilsson; Annika U Petersson; Iona Donnelly; Eugenia Sergeev; Gabriele M König; Evi Kostenis; Mariola Kurowska-Stolarska; Ashley Miller; Niek Dekker; Andrew B Tobin; Graeme Milligan
Journal:  J Biol Chem       Date:  2016-07-05       Impact factor: 5.157

8.  Small-Molecule Positive Allosteric Modulators of the β2-Adrenoceptor Isolated from DNA-Encoded Libraries.

Authors:  Seungkirl Ahn; Biswaranjan Pani; Alem W Kahsai; Eva K Olsen; Gitte Husemoen; Mikkel Vestergaard; Lei Jin; Shuai Zhao; Laura M Wingler; Paula K Rambarat; Rishabh K Simhal; Thomas T Xu; Lillian D Sun; Paul J Shim; Dean P Staus; Li-Yin Huang; Thomas Franch; Xin Chen; Robert J Lefkowitz
Journal:  Mol Pharmacol       Date:  2018-05-16       Impact factor: 4.436

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.